Communications

 

 

2008

2007

 2006

 

 

 2008
 

SMI - Clinical Trials in CNS (London, UK), November 25-26, 2008

  • Luthringer R. Cognitive testing in CNS drug development. 

15th IPEG meeting (Rouffach, France), September 24-27th, 2008

  • Boeijinga PH. How to optimise clinical trials ?
  • Luthringer R. EEG as a biological marker in Proof-Of-Concept trials.
  • Luthringer R. The use of q-EEG results. (IPEG guideline)
  • Soufflet L. Coherence & phase synchrony.
  • Staner L. Sleep EEG recording procedures & analyses in drug development. 

ESRS 2008 (Glasgow, UK), September 9-13, 2008

  • Berthomier C, Muzet A, Berthomier P, Prado J, Mattout J. Real-Time Automatic Measure of Drowsiness based on a Single EEG Channel.  

26th CINP Congress (Münich, Germany), July 13-17, 2008

  • Staner L. What do we know about sleep dysfunctions in mood disorders?

Belgian College of Neuropsychopharmacology and Biological Psychiatry (Lille, France), May 24, 2008

  • Staner L. Biomarqueurs, sommeil et neuropsychopharmacologie : vers une médecine translationnelle? 

Drug Development for Sleep Therapeutics (London, UK), February 7-8, 2008

  • Staner L. Clinical modelling of sleep disorders.

 

2007

2nd WEBP Meeting (West European Societies of Biological Psychiatry) (Strasbourg, France), December 13-15, 2007

  • Boeijinga PH, Soufflet L, Luthringer R. P300 differences in averaged Event Related Potentials and Event Related Oscillations : ketamine, apomorphine and the model for an endophenotype for schizophrenia.

46th Annual ACNP Meeting (Boca-Raton, Florida, USA),  December 9-13, 2007

  • Luthringer R, Boeijinga PH, Muzet M, Ferguson J. Comparison of the effects of benzodiazepines on induced gamma activity in auditory and visual cognitive tasks.

 SMI : Clinical trials in CNS (London, UK), November 26-27, 2007

  • Luthringer R. Human model investigations in CNS disorders.

4th Annual Pain Management Conference (London, UK), October 31-November 2, 2007

  • Luthringer R. Pain models in healthy subjects vs conventional Phase IIA trials.

 

29th IEEE EMBS Annual International Conference (Lyon, France), August 23-26, 2007

  • Chouvarda I, Papadelis C, Domis N, Staner L, Maglaveras N. Insomnia treatment based on physiological data analysis. Abstracted in Conf Proc IEEE Eng Med Biol Soc. 2007;1:6694-6696. 

 

Annual Meeting of ISMRM and ESMRMB (Berlin, Germany), May 19-25, 2007

  • Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Cisterni C, Luthringer R. Lorazepam effects on brain activity pattern related to cholecystokinin tetrapeptide (CCK-4)-induced panic attack.

Colloque International sur les Technologies Automobiles (CITA) (Sousse, Tunisia), April 26-27, 2007

  • Muzet T. La baisse de vigilance en situation de conduite automobile: de quels moyens d'étude disposons-nous?

Clinical development for chronic pain therapeutics (Amsterdam, Netherlands), March 29-30, 2007

  • Danjou P. Pain models in healthy subjects vs conventional Phase IIA trials. (Download)

SMI: Imaging in Neurology (London, UK), February 7-8th, 2007

  • Rémy Luthringer. Imaging on a surrogate endpoint.

2nd WASM (World Association of Sleep Medicine) (Bangkok, Thailand), February 4-8th, 2007

  • Staner L, Cornette F, Luthringer R. Age-related sleep alterations, depression and antidepressant drugs.

1st HUMABIO pan-european workshop (Basel, Switzerland), February 2nd, 2007

  • Muzet A. Potential of physiological signals for human authentication, validation and monitoring.

3rd Greek Congress on Sleep Apneas and Sleep Disorders (Athens, Greece), January 25-27th, 2007

  • Muzet A. Distinguishing between fatigue and sleepiness in the driving situation.
  • Muzet A. The use of micro and nano sensors in future PSG recordings.

  2006

Inter-Noise 2006 (Honolulu, USA), December 3-6th, 2006

  • Alain Muzet. Possible long-term health effects of sleep disruption and sleep reduction due to community noise.

SFRS 2006 (Albi, France), November 16-18th, 2006

  • Luc Staner. Comparaison en termes d'analyse visuelle et d'analyse spectrale du sommeil de deux modèles d'insomnie transitoire : l'effet première nuit et le sommeil après une sieste.
     

177th meeting of the Swiss Neurological Society (Interlaken, Switzerland), October 19-21st, 2006

  • Alain Muzet. Measuring sleepiness in drivers".

Physiological Modeling of MR Image Formation (Brussels, Belgium), October 18-20th, 2006

  • Nedelec JF, Viardot G, Chambron J , Macher JP. Robustness of brain ROIs texture analysis certified by a dataset randomisation method.

3rd World congress on Quality in Clinical Practice (Thessaloniki, Greece), September 28th-October 1st, 2006

  • Alain Muzet. Quality issues of PSG signals during the recording process.

Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Biomedizinische Technik (Zürich, Switzerland), September 6-9th, 2006

  • Sola J, Chetelat O, Dasen S, Pilloud P, Jacob N, Viardot G. SpO2 Monitor Integrated in a Finger Ring probe: results from a validation campaign.

EMBS'06 :  28th Annual International Conference of the IEEE (New York City, USA), August 30th-September 3rd, 2006 

  • Sola J, Castoldi S, Chetelat O, Correcon M, Dasen S, Droz S, Jacob N, Kormann R, Neumann V, Perrenoud A, Pilloud P, Verjus C, Viardot G. SpO2 Sensor embedded in a Finger Ring: design and implementation. Abstracted in Conf Proc IEEE Eng Med Biol Soc 2006:4295-4298.
6th Framework EU Integrated Project SENSATION International Conference (Basel, Switzerland), May 29-30th, 2006
  • Staner L, Viardot G, Boeijinga P, Rinaudo G, Jacob N, Luthringer R, Muzet A. Topographical modifications of EEG power spectra in a sleep deprivation paradigm induced by shift-work - Monitoring sleep and sleepiness - from physiology to new sensors.

MIP TEC :Leading European Event on Enabling Technologies for Drug Discovery (Basel, Switzerland), May 8-10th, 2006

  • Boeijinga PH. Biomarkers in mental illness: translational aspects of multi-sensor imaging of neuronal activity following administration of psychotropic drugs in healthy volunteers.

Séminiare Applications pharmaceutiques et médicales dans l’environnement MATLAB (Sèvres, France), April 6th, 2006

  • Maurice D. Présentation du logiciel HYPNOS (traitement des données sommeil)

Neuromeeting Bourgogne (France), January 18-21st, 2006

  • Boeijinga PH. Anomalies de l’activité à 40 Hz chez des patients schizophrènes et leur famille en 1er degré : réflexions sur le rôle des récepteurs NMDA.